Evercore ISI assumed coverage on shares of Homology Medicines (NASDAQ:FIXX) in a research note issued to investors on Monday morning. The brokerage issued an outperform rating and a $30.00 price target on the stock.
Separately, Cowen assumed coverage on Homology Medicines in a research note on Monday. They issued an outperform rating for the company.
NASDAQ FIXX opened at $20.64 on Monday. Homology Medicines has a 52 week low of $16.12 and a 52 week high of $24.40.
About Homology Medicines
There is no company description available for Homology Medicines Inc
Receive News & Ratings for Homology Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Homology Medicines and related companies with MarketBeat.com's FREE daily email newsletter.